Study of Adjuvant Radiochemotherapy for Gastric Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

December 19, 2013

Study Completion Date

August 18, 2017

Conditions
Stomach Neoplasms
Interventions
DRUG

cisplatinum combined with infusional fluorouracil (5 FU)

Continuous 5FU via intravenous PICC line + 4 doses of Cisplatin every 2 weeks

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188266 - Study of Adjuvant Radiochemotherapy for Gastric Cancer | Biotech Hunter | Biotech Hunter